← Back to Screener
Incannex Healthcare Limited American Depositary Shares (IXHL)
Price$3.25
Growth ScoreF
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-82.30%
Price vs S&P 500 (4W)-31.35%
VGM Score11.02
Market Capitalization$40.08M
All Metrics
Book Value / Share (Quarterly)$5.50
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-46.82%
Cash Flow / Share (Quarterly)$-1.30
Price vs S&P 500 (YTD)-79.74%
Gross Margin (TTM)116.40%
Net Profit Margin (TTM)-18137.76%
EPS (TTM)$-12.90
10-Day Avg Trading Volume0.21M
EPS Excl Extra (TTM)$-12.90
Revenue Growth (5Y)-31.02%
EPS (Annual)$-40.83
ROI (Annual)-350.18%
Gross Margin (Annual)48.22%
Net Profit Margin (5Y Avg)-42276.03%
Cash / Share (Quarterly)$5.44
ROA (Last FY)-229.30%
Revenue Growth TTM (YoY)-86.05%
EBITD / Share (TTM)$-2.76
ROE (5Y Avg)-184.95%
Operating Margin (TTM)-21430.61%
Cash Flow / Share (Annual)$-1.93
P/B Ratio0.53x
P/B Ratio (Quarterly)0.56x
Net Income / Employee (Annual)$-3,907,100
Net Interest Coverage (TTM)-87.46x
ROA (TTM)-76.11%
EPS Incl Extra (Annual)$-40.83
Current Ratio (Annual)2.86x
Quick Ratio (Quarterly)41.47x
3-Month Avg Trading Volume0.45M
52-Week Price Return-49.24%
Revenue / Employee (TTM)$0
P/S Ratio (Annual)466.06x
Asset Turnover (Annual)0.00x
52-Week High$49.80
Operating Margin (5Y Avg)-56531.83%
EPS Excl Extra (Annual)$-40.83
CapEx CAGR (5Y)72.05%
26-Week Price Return-66.37%
Quick Ratio (Annual)2.82x
13-Week Price Return-33.13%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)41.56x
Enterprise Value$-34.37M
Revenue / Share Growth (5Y)25.35%
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$7,200
Inventory Turnover (Annual)2.39x
Pretax Margin (Annual)-54517.44%
Cash / Share (Annual)$2.32
3-Month Return Std Dev144.86%
Net Income / Employee (TTM)$-4,034,500
ROE (Last FY)-350.18%
Net Interest Coverage (Annual)-729.91x
EPS Basic Excl Extra (Annual)$-40.83
Receivables Turnover (TTM)4.68x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-12.90
Receivables Turnover (Annual)7.14x
ROI (TTM)-81.02%
P/S Ratio (TTM)408.99x
Pretax Margin (5Y Avg)-42207.34%
Revenue / Share (Annual)$0.07
Forward P/E5.30x
Price vs S&P 500 (52W)-77.45%
Year-to-Date Return-68.81%
5-Day Price Return-4.83%
EPS Normalized (Annual)$-40.83
ROA (5Y Avg)-141.08%
Net Profit Margin (Annual)-54517.44%
Month-to-Date Return-23.69%
EBITD / Share (Annual)$-21.78
Operating Margin (Annual)-29373.26%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-184.95%
LT Debt / Equity (Quarterly)2.47x
EPS Basic Excl Extra (TTM)$-12.90
P/B Ratio (Annual)0.47x
Inventory Turnover (TTM)-0.41x
Pretax Margin (TTM)-18107.14%
Book Value / Share (Annual)$2.07
Price vs S&P 500 (13W)-42.88%
Beta1.86x
P/FCF (Annual)114.58x
Revenue / Share (TTM)$0.00
ROE (TTM)-81.02%
52-Week Low$2.49
gGradeF
mGradeF
vgmGradeF
Show chart for
Earnings Surprise History
Q3 26-11.23est. -0.94
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IXHLIncannex Healthcare Limited American Depositary Shares | — | F | F | $3.25 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Incannex Healthcare is a clinical-stage pharmaceutical company developing cannabis-based therapeutics for Obstructive Sleep Apnea, Traumatic Brain Injury, Rheumatoid Arthritis, and various inflammatory conditions. The company holds an Australian license to import, export, and distribute medicinal cannabis and has commercialized a cannabinoid product line. Its research and development extends to both cannabis and psychedelic medicine applications.